1. Home
  2. OPAL vs ENTX Comparison

OPAL vs ENTX Comparison

Compare OPAL & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPAL Fuels Inc.

OPAL

OPAL Fuels Inc.

HOLD

Current Price

$2.39

Market Cap

65.8M

Sector

Utilities

ML Signal

HOLD

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.13

Market Cap

62.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPAL
ENTX
Founded
1998
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.8M
62.6M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
OPAL
ENTX
Price
$2.39
$1.13
Analyst Decision
Sell
Strong Buy
Analyst Count
3
1
Target Price
$2.72
$10.00
AVG Volume (30 Days)
156.7K
153.1K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
650.00
N/A
EPS
0.15
0.25
Revenue
$348,975,000.00
$42,000.00
Revenue This Year
$12.84
N/A
Revenue Next Year
$9.11
N/A
P/E Ratio
$16.17
$4.75
Revenue Growth
16.34
N/A
52 Week Low
$1.65
$0.91
52 Week High
$4.08
$3.22

Technical Indicators

Market Signals
Indicator
OPAL
ENTX
Relative Strength Index (RSI) 46.04 44.54
Support Level $2.03 $0.96
Resistance Level $2.50 $1.61
Average True Range (ATR) 0.10 0.11
MACD -0.01 0.01
Stochastic Oscillator 1.41 12.50

Price Performance

Historical Comparison
OPAL
ENTX

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: